Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 5Completed 5Unknown 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostate Cancer Patients Undergoing Radical Prostatectomy 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × Infusions, Intravenous × Clear all
NCT06490718 2025-09-08

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Chinese University of Hong Kong

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms

NCT07024030 2025-06-17

DGPR1008

The Affiliated Hospital of Qingdao University

Phase 2 Completed
24 enrolled
Genitourinary

Prostate Cancer Patients Undergoing Radical Prostatectomy

NCT03238248 2024-11-04

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
71 enrolled 13 charts
Myeloid

Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04477772 2024-05-16

A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China

Shanghai Junshi Bioscience Co., Ltd.

Phase 1 Completed
71 enrolled
Lymphoid

Lymphoma

NCT04866498 2021-04-29

Pharmacotherapy Personalization of Cancer Patients

Poznan University of Medical Sciences

Completed
22 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡